Medical devices, healthcare technology and the business of care
510(k) clearance · K262196

Invisalign System

Align Technology, Inc. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONK262196

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on September 25, 2026 for the Invisalign System, submitted by Align Technology, Inc. under K262196, a traditional 510(k) received June 29, 2026. The device is classified under 21 CFR 872.5470 with product codes PNN and NXC, in the dental specialty. SESE denotes clearance rather than premarket approval.

The submission describes a modification to the cleared predicate Invisalign System (K252380): an optional AI-enabled prediction service added to the backend 3D treatment planning software to support aligner activation design. The summary states no change to intended use, indications, aligner design or the end-to-end user workflow, and that the AI model is static and non-adaptive with no direct user interaction. The summary reports software verification and validation and performance validation meeting pre-specified acceptance criteria; detailed results and subgroup analyses are not in the public excerpts, so their magnitude remains unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Sep 25, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262196
Regulatory pathway
510(k) premarket notification
Product code
PNN
Decision code
SESE
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Orthodontic Software.

Product code
PNN
FDA device class
2

FDA decision timeline

  1. K262196 received

    Application receipt date recorded by FDA.

  2. K262196 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PNN

Product / regulatory recordCompanyPathwayDecision dateSource
LuxDesignK260421
LuxCreo, Inc.510(k) clearanceOct 23, 2026FDA
InnoDtech, Inc.510(k) clearanceOct 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Align Technology, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
San Jose, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records